BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 10852640)

  • 1. Pancreatic cancer: a review of emerging therapies.
    Rosenberg L
    Drugs; 2000 May; 59(5):1071-89. PubMed ID: 10852640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotherapeutic approaches to pancreatic cancer.
    Rosenberg L; Lipsett M
    Expert Opin Biol Ther; 2003 Apr; 3(2):319-37. PubMed ID: 12662145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic cancer: does octreotide offer any promise?
    Rosenberg L
    Chemotherapy; 2001; 47 Suppl 2():134-49. PubMed ID: 11275707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular therapy in pancreatic adenocarcinoma.
    MacKenzie MJ
    Lancet Oncol; 2004 Sep; 5(9):541-9. PubMed ID: 15337483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutic directions for advanced pancreatic cancer: cell cycle inhibitors, stromal modifiers and conjugated therapies.
    Matera R; Saif MW
    Expert Opin Emerg Drugs; 2017 Sep; 22(3):223-233. PubMed ID: 28783977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer.
    Baines AT; Martin PM; Rorie CJ
    Prog Mol Biol Transl Sci; 2016; 144():277-320. PubMed ID: 27865460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Systemic Treatment and Emerging Therapeutic Strategies in Pancreatic Adenocarcinoma.
    Yee NS; Kazi AA; Yee RK
    Curr Clin Pharmacol; 2015; 10(4):256-66. PubMed ID: 26548903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New targeted therapies in pancreatic cancer.
    Seicean A; Petrusel L; Seicean R
    World J Gastroenterol; 2015 May; 21(20):6127-45. PubMed ID: 26034349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy for resectable pancreatic adenocarcinoma: review of the current treatment approaches and future directions.
    Antoniou G; Kountourakis P; Papadimitriou K; Vassiliou V; Papamichael D
    Cancer Treat Rev; 2014 Feb; 40(1):78-85. PubMed ID: 23810287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation of recent advances and discoveries in molecular biology and immunology in the diagnosis and treatment of pancreatic cancer.
    Albo D; Farrow B; Berger DH
    Surg Oncol Clin N Am; 2008 Apr; 17(2):357-76, ix. PubMed ID: 18375357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: chemotherapy for pancreatic cancer.
    Shore S; Raraty MG; Ghaneh P; Neoptolemos JP
    Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1049-69. PubMed ID: 14653825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the management of pancreatic adenocarcinoma.
    Karakas Y; Lacin S; Yalcin S
    Expert Rev Anticancer Ther; 2018 Jan; 18(1):51-62. PubMed ID: 29125367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for pancreatic cancer.
    Tseng JF; Mulligan RC
    Surg Oncol Clin N Am; 2002 Jul; 11(3):537-69. PubMed ID: 12487056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of gene therapy for pancreatic cancer.
    Ramírez PJ; Vickers SM
    Curr Surg; 2004; 61(1):84-92. PubMed ID: 14972178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives in the treatment of pancreatic adenocarcinoma.
    Cid-Arregui A; Juarez V
    World J Gastroenterol; 2015 Aug; 21(31):9297-316. PubMed ID: 26309356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer: from molecular pathogenesis to targeted therapy.
    Strimpakos A; Saif MW; Syrigos KN
    Cancer Metastasis Rev; 2008 Sep; 27(3):495-522. PubMed ID: 18427734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials.
    Mosquera C; Maglic D; Zervos EE
    Cancer Genet; 2016 Dec; 209(12):567-581. PubMed ID: 27613577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising new therapies in advanced pancreatic adenocarcinomas.
    Kundranda M; Kachaamy T
    Future Oncol; 2014 Dec; 10(16):2629-41. PubMed ID: 25531049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic developments in pancreatic cancer: current and future perspectives.
    Neoptolemos JP; Kleeff J; Michl P; Costello E; Greenhalf W; Palmer DH
    Nat Rev Gastroenterol Hepatol; 2018 Jun; 15(6):333-348. PubMed ID: 29717230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer.
    Giovannetti E; Mey V; Nannizzi S; Pasqualetti G; Del Tacca M; Danesi R
    Mol Cancer Ther; 2006 Jun; 5(6):1387-95. PubMed ID: 16818496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.